Editorial Policies

Diabetes Therapy will endeavor to publish results from all well-designed and balanced studies in support of concerns raised in the GPP2 guidelines relating to publication bias.

Submissions to Diabetes Therapy should conform to the standards outlined in the "Uniform Requirements for Manuscript submitted to Biomedical Journals," prepared by the International Committee of Medical Journal Editors (ICMJE). Randomized controlled study reports should present information specified on the CONSORT checklist. For the transparency of systematic reviews or a meta-analysis please ensure your study complies with the PRISMA statement.

Authorship

All named authors should meet the authorship guidelines of the ICMJE. All individuals who do not meet the criteria for authorship should be listed in a Contributorship section at the end of the manuscript.

Diabetes Therapy views medical writers as legitimate contributors and requests that their roles and affiliations are declared in a Contributorship section at the end of the manuscript.

Transparency

We request that personal, commercial, academic, or financial interests are declared thereby ensuring transparency.

Guidelines on Data

Diabetes Therapy will publish data that has been pre-registered on clinical trial websites. We do ask, however, that if a trial registration number is available, it is included at the end of the abstract.

Presentation at scientific meetings (in the form of abstracts or posters) is not considered to constitute full publication. However, we ask that the manuscript makes reference to such presentation of the data.